Both conditions are characterized by increased activated platelet activation, with circulating levels of the platelet marker thrombospondin-1 (TSP-1) recently demonstrated to be significantly higher in patients with GCA and PMR as compared to healthy controls (2–4). The gene discussed is THBS1; the disease is temporal arteritis.